Download FREE Report Sample
Download Free sampleGlaucoma is one of the largest segments in the global ophthalmic market. Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible. The good news is that glaucoma can be managed if detected early, and that with medical and/or surgical treatment, most people with glaucoma will not lose their sight.
Glaucoma Treatment Market contains market size and forecasts of Glaucoma Treatment in Global, including the following market information:
Global Glaucoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glaucoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prostaglandin Analogs (PGAs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glaucoma Treatment include Novartis, Allergan, Pfizer, Akorn, Teva, Bausch & Lomb, Otsuka Pharmaceutical, Santen and Lunan Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Glaucoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glaucoma Treatment Market, by Product, 2017-2022, 2023-2028 ($ millions)
Global Glaucoma Treatment Market Segment Percentages, by Product, 2021 (%)
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Others
Global Glaucoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Glaucoma Treatment Market Segment Percentages, by Application, 2021 (%)
Clinic
Pharmacy
Other
Global Glaucoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Glaucoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glaucoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glaucoma Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
